SecBot SecBot
6-K ·Filed Apr 28, 2026

GLAXF

GSK plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001654954-26-003992
Notable filing: 6-K
Actionable Insight • Neutral

Routine CFO equity vesting with no immediate market signal. The two-year lock-up prevents any near-term insider selling. Monitor the 20-F annual report for broader financial context, but this filing alone does not warrant trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
GLAXF ▼ -7.32% at T+60d
NEUTRAL call -7.32% · α vs SPY -11.31% · entry $27.31 → $25.31
Entry = T+0 close
Apr 28, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.01%
$27.31
settled 6mo ago
T+5d
-0.48%
call -0.48% · α -2.17%
$27.18
settled 6mo ago
T+20d
-6.63%
call -6.63% · α -12.10%
$25.50
settled 5mo ago
T+60d
-7.32%
call -7.32% · α -11.31%
$25.31
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

GSK filed a Form 6-K reporting the vesting of a 2023 Performance Share Plan award for CFO Julie Brown. 243,880 shares vested at £0.00 exercise price on April 27, 2026, with an 82% vesting rate and a two-year holding period. This is a routine equity compensation event with no material financial impact.

Key Facts

  • CFO Julie Brown received 243,880 vested shares under the 2023 Performance Share Plan
  • Vesting occurred on April 27, 2026, at £0.00 per share
  • 82% of the award vested, 18% lapsed
  • Vested shares are subject to an additional two-year holding period
  • Closing price on vesting date was £20.16 per share

Financial Impact

No cash consideration; 243,880 shares vested at £0.00. Based on £20.16 closing price, the notional value is approximately £4.9 million, but shares are subject to a two-year holding period.

dilution

Risk Factors

  • No material risk identified from this filing

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003992
Document: 0001654954-26-003992-index-headers.html0001654954-26-003992
Document: 0001654954-26-003992-index.html0001654954-26-003992
Document: 0001654954-26-003992.txt0001654954-26-003992
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
20w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
20w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Closed — Opens in 9h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026